As the number of surgical procedures performed outside hospitals continues to increase, ambulatory surgical centers (ASCs) need to develop policies for managing malignant hyperthermia a rare but serious reaction to anesthetics, according to an expert panel report in the January issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS). The report includes a guide for ASCs to follow in developing specific plans for transferring patients with malignant hyperthermia (MH) to a nearby hospital for advanced care. The lead author of the expert panel report was Dr Marilyn Green Larach of Penn State College of Medicine, Hershey, Pa. ASCs Must Have a Plan for Managing Rare Complication Malignant hyperthermia is a rare condition in which genetically susceptible people develop rapid increases in body temperature and muscle rigidity in response to certain anesthetics and other drugs.
According to the Department of Health, their main concern is the wellbeing of women who have had PiP breast implants. For this reason, an expert group led by Professor Sir Bruce Keogh, NHS Medical Director, has been asked to examine all available data and evidence on PiP breast implants. The experts concluded that: There is no association with PiP breast implants and cancer Advice given by the MHRA still stands That there is insufficient evidence to recommend routine extraction of PiP breast implants. However, the group explains that these implants should have never been implanted in women in the first place, as they are made up of non-medical grade silicone. The Department of Health knows that this data will be a worrying for women who have PiP implants. Those who performed the implantations should properly support these women.
A new study finds that low concentrations of the chemical methylisothiazolinone has subtle but measurable negative effects on the neural development of tadpoles. The chemical is found in some cosmetics, although the study does not provide any evidence that cosmetics are unsafe for humans. Scientists, health officials, and manufacturers already know that a chemical preservative found in some products, including cosmetics, is harmful to people and animals in high concentrations, but a new Brown University study in tadpoles reports that it can also interrupt neurological development even in very low concentrations. In the cosmetics industry, the biocide methylisothiazolinone or MIT, is considered safe at concentrations of less than 100 parts per million. Lab studies, however, have found that lower concentrations affected the growth of animal neurons.
Varicose veins are enlarged, swollen, and tortuous (twisting) veins, frequently linked to faulty valves in the vein. They are generally blue or dark purple. People with bulging and/or lumpy varicose veins on their legs may experience aching and heavy limbs. Sometimes, in very severe cases, the varicose veins may rupture, or varicose ulcers may form on the skin. In healthy veins, the valves within them stop the blood from staying stagnant or flowing back - they open and close so that the blood flows in only one direction. Damaged or weakened valves may allow the blood to flow back and accumulate in the vein, making it varicose. Varicose simply means enlarged or swollen. According to UK health authorities, up to 30% of all adults are affected by varicose veins. They are more common in adult females than males.
Weight loss surgery is not a cure for type 2 diabetes, but it can improve blood sugar control, according to a new study published in the British Journal of Surgery. Whereas some previous studies have claimed that up to 80 per cent of diabetes patients have been cured following gastric bypass surgery, researchers at Imperial College London found that only 41 per cent of patients achieve remission using more stringent criteria. The research was funded by the National Institute for Health Research (NIHR) Biomedical Research Centre awarded to Imperial College Healthcare NHS Trust and Imperial College London. Obesity is a major risk factor for type 2 diabetes. Worldwide, 80 per cent of people with type 2 diabetes are overweight or obese at the time of diagnosis. Diabetes is normally treated by using insulin injections and drugs to control blood sugar.